12:00 AM
Apr 01, 2013
 |  BC Week In Review  |  Clinical News  |  Clinical Status

ReN009: Phase I start

At mid-year, ReNeuron will begin a dose-escalation, European Phase I trial to evaluate intramuscular injections of ReN009 in 9 patients with peripheral...

Read the full 90 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >